Canada markets open in 4 hours 21 minutes

Evgen Pharma plc (EVG.L)

LSE - LSE Delayed Price. Currency in GBp (0.01 GBP)
Add to watchlist
0.8190+0.0190 (+2.37%)
As of 09:47AM BST. Market open.
Currency in GBp

Valuation Measures4

Market Cap (intraday) 3.42M
Enterprise Value -309.23k
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)2.62
Price/Book (mrq)0.87
Enterprise Value/Revenue -0.37
Enterprise Value/EBITDA 0.07

Trading Information

Stock Price History

Beta (5Y Monthly) 1.44
52-Week Change 3-78.67%
S&P500 52-Week Change 325.01%
52 Week High 34.0500
52 Week Low 30.7000
50-Day Moving Average 30.9365
200-Day Moving Average 31.7370

Share Statistics

Avg Vol (3 month) 31.52M
Avg Vol (10 day) 31.4M
Shares Outstanding 5427.35M
Implied Shares Outstanding 6298.45M
Float 8217.09M
% Held by Insiders 132.42%
% Held by Institutions 127.80%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Currency in GBP.

Fiscal Year

Fiscal Year Ends Mar 31, 2023
Most Recent Quarter (mrq)Sept 30, 2023

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-368.43%

Management Effectiveness

Return on Assets (ttm)-45.52%
Return on Equity (ttm)-60.57%

Income Statement

Revenue (ttm)838k
Revenue Per Share (ttm)0.00
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -4.33M
Net Income Avi to Common (ttm)-3.35M
Diluted EPS (ttm)-0.0100
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)3.73M
Total Cash Per Share (mrq)0.01
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)10.39
Book Value Per Share (mrq)0.01

Cash Flow Statement

Operating Cash Flow (ttm)-3.52M
Levered Free Cash Flow (ttm)-2.81M